MicroDose considers strong and broad Intellectual Property protection to be a key strategy for sustaining competitive advantage. All of MicroDose’s core technologies are supported by issued US and international patents and pending patent applications. MicroDose performs all of its own core R&D and as such all of its core technologies have been developed internally and are wholly owned by MicroDose. MicroDose, in turn, makes their intellectual property available to partners under appropriate licensing agreements. MicroDose’s current intellectual property portfolio consists of the following:

  • 13 US issued patents
  • 12 US patent applications pending
  • 10 International issued patents
  • 44 International patents pending on a regional or specific country basis
  • 3 Trademarks registered and pending in the US and internationally





  • Please visit our User Agreement. Your continued use of this site will automatically constitute your agreement to be bound by all the terms and conditions of the User Agreement.

    ©2004 MicroDose Technologies, Inc.